Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

NCT07264426 is registered in ClinicalTrials.gov with argenx as lead sponsor.

NCT NCT07264426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Lead sponsor
argenx
Phase
Observational
Overall status
Recruiting
Start date
August 11, 2025
Completion date
October 31, 2029
Enrollment
200 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyradiculoneuropathy, cidp, cidp (chronic inflammatory demyelinating polyradiculoneuropathy)